Electroconvulsive Therapy (ECT) for Agitation in Dementia (AD)

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1. 1This trial used electroconvulsive therapy — which most people associate with treating severe depression — to manage agitation in Alzheimer's dementia, so can you explain why ECT would even be considered for behavioral symptoms like this, and how it's thought to work in that context?
2. 2The trial measured agitation using something called the CMAI total score — can you help me understand what that scale actually captures, and whether the changes seen in this completed study were meaningful enough in real life to make a difference for someone living with dementia?
3. 3Since this trial is listed as Phase NA, which often means it's a very early or exploratory study, what does that tell us about how much we know so far about the safety and effectiveness of ECT for dementia-related agitation compared to other options?
4. 4ECT typically requires anesthesia and repeated sessions, which can be demanding — given the physical and cognitive vulnerabilities that come with Alzheimer's, what are the specific risks my loved one's care team would need to weigh before considering this kind of treatment?
5. 5Are there standard medications or non-drug behavioral approaches for agitation in Alzheimer's dementia that we haven't fully tried yet, and would it make sense to explore those before even discussing whether something like ECT could be relevant for our situation?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.